H1N1 News and Research

RSS

Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.

New research could pave way for better influenza vaccines

Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the severity of illness, according to new research published in Cell.

6 Apr 2018

Kids under two at greater risk of flu related death

Seasonal flu deaths have been studied and it has been seen that since 2009, over the six seasons of flu with the H1N1 strain of the virus, children under 2 years of age are most likely to succumb. Less than one third of these babies that died had received a vaccination against the flu virus.

14 Feb 2018

Far-UVC light may offer solution to eradicating airborne flu viruses

Continuous low doses of far ultraviolet C light can kill airborne flu viruses without harming human tissues, according to a new study at the Center for Radiological Research at Columbia University Irving Medical Center.

9 Feb 2018

Universal vaccine produces long-lasting immunity against influenza A viruses in mice

Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a study led by Georgia State University.

24 Jan 2018

Study illustrates role of specific antibodies in protection against influenza

People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according to a new study published in mBio.

23 Jan 2018

Expert discusses how to stay healthy during flu season

This year's influenza outbreak is already the most widespread on record since health officials began keeping track about a dozen years ago, with millions of Americans being infected by emerging and current strains such as the dominant H3N2.

18 Jan 2018

New universal flu vaccine moves to clinical trial phase and could be a reality soon

Alphabet’s venture arm called Google Ventures earlier is one of the supporters of a mega projects that is developing a vaccine for flu that is safe and effective. Vaccitech from United Kingdom is working towards development of the vaccine and Alphabet has shown its support by contributing $27.6 million in new funding. The funds would be used conduct clinical trials and try the new vaccine.

16 Jan 2018

Past exposures influence immune response in children with acute respiratory tract infections

Acute respiratory tract infections (ARTI) are the leading global cause of death in early childhood, according to the Centers for Disease Control and Prevention.

12 Jan 2018

Early testing for influenza symptoms can limit severe, life-threatening disease

As flu season picks up steam across the country, it's important for people to be tested very early after symptoms that are compatible with influenza start, since there are effective treatments that can limit severe, life-threatening disease and curtail transmission to others.

12 Jan 2018

Novel partnership creates Europe's first antimicrobial nitrile gloves

Unigloves new Fortified single use gloves incorporate silver ion technology from BioCote, which has been scientifically proven to destroy 90% of harmful bacteria within just 15 minutes and 99.5% in only two hours.

11 Jan 2018

Lactic acid bacteria can offer protection against subtypes of influenza A virus

Lactic acid bacteria, commonly used as probiotics to improve digestive health, can offer protection against different subtypes of influenza A virus, resulting in reduced weight loss after virus infection and lower amounts of virus replication in the lungs, according to a study led by Georgia State University.

13 Dec 2017

Time-lapse imaging reveals how antimicrobial treated surfaces kill superbugs in two hours

Experts at the University of Warwick have produced microscopic footage of the potentially deadly E. coli bacteria being wiped out in just two hours on an antimicrobial treated ‘intelligent’ surface.

13 Dec 2017

Altering genetic mutation could enhance FluMist vaccine’s protective effect

Researchers at Johns Hopkins Bloomberg School of Public Health have discovered a genetic mutation in the FluMist intranasal flu vaccine that has the potential to be altered to enhance the vaccine's protective effect.

30 Nov 2017

Collaborative research identifies broadly cross-protective vaccines for H3N2 influenza

A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine candidate that protects against multiple co-circulating strains of H3N2 influenza isolated over five seasons following testing in mouse and ferret models.

2 Nov 2017

New flu forecasting tool makes better predictions by factoring evolution of virus

Each year, public health officials monitor the spread of influenza to identify which flu strains need to go into that year's vaccines and where outbreaks will occur. But it can be difficult to predict how bad a particular flu season will be until people actually start getting sick.

25 Oct 2017

Study shows no relation between swine flu vaccination and increased risk of type 1 diabetes

There has been a fear that the swine flu vaccine, Pandemrix, would increase the risk of autoimmune diseases other than narcolepsy.

9 Oct 2017

British technology offers ultimate surface protection against Aussie flu virus

With breaking news of a more severe Aussie Flu strain heading for the UK, there is a British technology that provides the ultimate surface protection against the virus - reducing it by 99.99%!

30 Sep 2017

BioCote Silver Ion Antimicrobial Technology makes surfaces inhospitable to influenza viruses

Strike a chord please, especially in light of the BMJ's article on Tuesday about the ineffectiveness of the flu vaccine for elderly last year - just wanted to make you also aware of the ultimate surface protection against viruses like H1N1, plus all the proliferating superbugs.

11 Sep 2017

Influenza vaccination rates in children may decrease without option of nasal spray

Influenza vaccination rates in children may have decreased for the 2016-17 influenza season because of a recommendation by the Centers for Disease Control and Prevention that the nasal spray version of the vaccine not be used, according to Penn State College of Medicine researchers.

24 Aug 2017

Eggshell-like mineral layer on avian flu viruses may be cause for human infections

Avian flu can be transmitted from birds to humans; transmission among humans, however, is limited. The reason may be an eggshell-like mineral layer that the virus acquires due to the high calcium concentration in the intestines of birds.

18 Aug 2017